Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/77782
Title: | Adenosquamous carcinoma of the uterine cervix – impact of histology on clinical management |
Authors: | Yordanov, Angel Kostov, Stoyan Slavchev, Stanislav Strashilov, Strahil Konsoulova, Assia Calleja-Agius, Jean Di Fiore, Riccardo Suleiman, Sherif Kubelac, Paul Vlad, Catalin Achimas-Cadariu, Patriciu Vasileva-Slaveva, Mariela |
Keywords: | Cancer -- Prognosis Cervix uteri -- Cancer Rare diseases |
Issue Date: | 2021 |
Publisher: | Dove Medical Press Ltd. |
Citation: | Yordanov, A., Kostov, S., Slavchev, S., Strashilov, S., Konsoulova, A., Calleja-Agius, J.,…Vasileva-Slaveva, M. (2021). Adenosquamous carcinoma of the uterine cervix – impact of histology on clinical management. Cancer Management and Research, 13, 4979-4986. |
Abstract: | Introduction: Historically, the incidence rate of cervical cancer (CC) in Eastern Europe and particularly in Bulgaria has constantly been higher than that in the other European countries. Adenosquamous carcinoma (ASC) is a rare histological subtype of CC with incidence rate of less than 6 per 100,000. We aimed to analyze the epidemiology and prognosis of all Bulgarian patients with ASC, registered at the Bulgarian National Cancer Registry (BNCR), and to compare patients’ characteristics and outcomes with those of patients, treated at a large specialized institution – the Department of Gynecologic Oncology, University Hospital in Pleven, Bulgaria. Materials and Methods: This is a retrospective study of all cases of ASC, registered at the BNCR for a 10-year period of time. The Kaplan–Meier analysis with Log rank test was used to estimate the significant differences. Results: The incidence rate of ASC was calculated as 3.2% of all CC registered in BNCR and 4.97% of all stage I patients, treated in our department. The 5-year overall survival (OS) rate of all patients with ASC tumors from the registry was 50.5%. A total of 171 (48.4%) of the patients had T1 tumors and a 5-year OS of 67.1%. Lymph node status was a significant prognostic factor for OS (p=0.001). Thirty-one patients with T1 tumors and ASC histology were treated in our department for the same period of time. Lymph node metastases were found in 10 of them (32.2%). The 5-year observed OS in ASC group was 74.19%. Conclusion: The histological subtype of cancer of the uterine cervix has an impact on prognosis and should not be simply considered as a descriptive characteristic but a poor prognostic feature and should be an integral part of the decision-making in clinical management of patients. |
URI: | https://www.um.edu.mt/library/oar/handle/123456789/77782 |
Appears in Collections: | Scholarly Works - FacM&SAna |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Adenosquamous_carcinoma_of_the_uterine_cervix–impact_of_histology_on_clinical_management_2021.pdf | 1.41 MB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.